Patrick J. Grohar
Impact in
-
- Sarcoma Diagnosis and Treatment
- Oncology top 10%
- CAR-T cell therapy research
Papers in
-
- Sarcoma Diagnosis and Treatment 33
-
- Protein Degradation and Inhibitors 11
- RNA modifications and cancer 6
- Cancer-related gene regulation 5
- Ubiquitin and proteasome pathways 5
- Co-authors
- Lee J. Helman (13 shared papers)Xiaolin Wan (2 shared papers)Choh Yeung (4 shared papers)Javed Khan (3 shared papers)Qing-Rong Chen (2 shared papers)Laurie B. Griffin (2 shared papers)Chand Khanna (2 shared papers)Arnulfo Mendoza (2 shared papers)
- Journals
- Cancer Research (8 papers)Journal of Clinical Oncology (5 papers)Clinical Cancer Research (4 papers)Molecular Cancer Therapeutics (2 papers)Cell Reports (2 papers)
- Partner nations
- United StatesItalyGermany
In The Last Decade
Patrick J. Grohar
43 papers receiving 1.7k citations
Patrick J. Grohar's Hit Papers
Peers
Comparison fields: 5 of 87
- Pulmonary and Respiratory Medicine 623
- Oncology 444
- Molecular Biology 1.1k
- Cancer Research 234
- Pathology and Forensic Medicine 246
Countries citing papers authored by Patrick J. Grohar
This map shows the geographic impact of Patrick J. Grohar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick J. Grohar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick J. Grohar more than expected).
Fields of papers citing papers by Patrick J. Grohar
This network shows the impact of papers produced by Patrick J. Grohar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick J. Grohar. The network helps show where Patrick J. Grohar may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick J. Grohar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism Hit paper breakdown → | 2006 | 630 |
| 2 | 2011 | 164 | |
| 3 | 2011 | 97 | |
| 4 | 2016 | 68 | |
| 5 | 2013 | 60 | |
| 6 | 2016 | 57 | |
| 7 | 2017 | 56 | |
| 8 | 2004 | 54 | |
| 9 | 2001 | 49 | |
| 10 | 2012 | 36 | |
| 11 | 2013 | 36 | |
| 12 | 2016 | 36 | |
| 13 | 2017 | 32 | |
| 14 | 2019 | 31 | |
| 15 | 2020 | 31 | |
| 16 | 2016 | 30 | |
| 17 | 2019 | 24 | |
| 18 | 2021 | 23 | |
| 19 | 2017 | 19 | |
| 20 | 2016 | 18 |
About Patrick J. Grohar
Patrick J. Grohar is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research, Pathology and Forensic Medicine and Oncology, having authored 45 papers that have together received 1.7k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (33 papers), Protein Degradation and Inhibitors (11 papers), Lymphoma Diagnosis and Treatment (7 papers), RNA modifications and cancer (6 papers), Cancer Genomics and Diagnostics (5 papers), Cardiac tumors and thrombi (5 papers), Cancer-related gene regulation (5 papers) and Ubiquitin and proteasome pathways (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (623 citations), Oncology (444 citations), Molecular Biology (1.1k citations), Cancer Research (234 citations) and Pathology and Forensic Medicine (246 citations). Patrick J. Grohar has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Lee J. Helman, Xiaolin Wan, Choh Yeung, Javed Khan, Qing-Rong Chen, Laurie B. Griffin, Chand Khanna, Arnulfo Mendoza, Yves Pommier and Girma M. Woldemichael. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Clinical Cancer Research, Molecular Cancer Therapeutics and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.